Company: VCYT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001384101-25-000051
Chunk: 62

Company: VERACYTE, INC.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 62
---
 Chief Executive Officer and other NEOs, who are crucial to the execution of our next phase of growth by giving insight into the retentive value of the PSU awards. Companies competing for our top executive talent could use the thresholds’ rigor and the significant challenge of achieving the full award, depending on how many tranches have been earned and what remains of the performance period, to undercut the value of the PSU awards by offering a sign-on bonus or a more easily achievable compensation package to induce our NEOs to leave Veracyte. While we are not disclosing the thresholds in advance, we plan to appropriately disclose applicable achievements in a fiscal year in the following year’s proxy statement.

#### Prior Year PSUs – Achievement
The following table and footnotes summarizes PSU awards that were eligible to be achieved during 2024.

| PSU Awards      
 (Year of Grant) |     | Performance Period          |     | Performance Metric                                                                                                                                        |     | Achievement                                                                                                                       
 (%)                                                                                                                               |
| 2022 PSUs(1)    |     | 3 years ended December 2024 |     | Revenue calculated in accordance with U.S. GAAP, adjusted for foreign currency exchange impact and portfolio decisions                                    |     | 118.8% of target level performance of $440 million in Revenue                                                                     
 118.8% PSUs earned; vested in February 2025                                                                                       |
| 2023 PSUs(1)    |     | 2 years ended December 2024 |     | Revenue calculated in accordance with U.S. GAAP, adjusted for foreign currency exchange impact and portfolio decisions                                    
 Ending Cash, Cash Equivalents and Short-Term Investment balance as of December 31, 2024, excluding the impact of acquisitions and capital raises and uses |     | 139.7% of target level performance of $397 million in Revenue and max of 150% of target level performance of $175 million in Cash 
 143.8% PSUs earned; vested in February 2025                                                                                       |

(1) Any achieved PSUs vested upon the date the achievement was certified by the Compensation Committee during the first quarter of 2025, subject to the officer’s continued service to Veracyte.

Additional Compensation Practices and Policies

#### Compensation Recovery Policy
On April 23, 2023, our Board of Directors adopted a compensation recovery policy (the “Clawback Policy”) intended to comply with the requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act, as implemented by Nasdaq rules